Literature DB >> 35769961

Rare Treatable Cause of Demyelinating Leukoencephalopathy That One Cannot Afford to Miss.

Vykuntaraju K Gowda1, Sukanya Vignesh1, Balamurugan Nagarajan1, Varunvenkat M Srinivasan1, Manojna Battina1, Maya Bhat2, Rita Christopher3.   

Abstract

Biotinidase deficiency is a treatable neurometabolic disorder. It usually presents during the first year of life with seizures, ataxia, hypotonia, vision and hearing disturbance, alopecia, and skin rashes. It can have various neuroimaging findings but demyelinating leukoencephalopathy is an unusual finding in children with biotinidase deficiency that can cause diagnostic challenge as it can radiologically mimic perinatal hypoxic-ischemic encephalopathy or other leukodystrophies. It reverses with early diagnosis and treatment with biotin supplementation and the outcome is rewarding. Thieme. All rights reserved.

Entities:  

Keywords:  biotinidase; demyelination; leukoencephalopathy; neurometabolic disorders

Year:  2020        PMID: 35769961      PMCID: PMC9236727          DOI: 10.1055/s-0040-1721678

Source DB:  PubMed          Journal:  J Pediatr Genet        ISSN: 2146-460X


  7 in total

1.  Cutaneous and neurologic manifestations of biotinidase deficiency.

Authors:  P C Navarro; A Guerra; J G Alvarez; F J Ortiz
Journal:  Int J Dermatol       Date:  2000-05       Impact factor: 2.736

2.  Hearing loss is a common feature of symptomatic children with profound biotinidase deficiency.

Authors:  Barry Wolf; Robert Spencer; Tucker Gleason
Journal:  J Pediatr       Date:  2002-02       Impact factor: 4.406

Review 3.  The neurology of biotinidase deficiency.

Authors:  Barry Wolf
Journal:  Mol Genet Metab       Date:  2011-06-12       Impact factor: 4.797

4.  Biotinidase deficiency: a treatable leukoencephalopathy.

Authors:  S Grünewald; M P Champion; J V Leonard; J Schaper; A A M Morris
Journal:  Neuropediatrics       Date:  2004-08       Impact factor: 1.947

5.  Biotinidase deficiency: a reversible metabolic encephalopathy. Neuroimaging and MR spectroscopic findings in a series of four patients.

Authors:  Shrinivas Desai; Karthik Ganesan; Anaita Hegde
Journal:  Pediatr Radiol       Date:  2008-06-11

6.  Technical standards and guidelines for the diagnosis of biotinidase deficiency.

Authors:  Tina M Cowan; Miriam G Blitzer; Barry Wolf
Journal:  Genet Med       Date:  2010-07       Impact factor: 8.822

Review 7.  Biotinidase deficiency: "if you have to have an inherited metabolic disease, this is the one to have".

Authors:  Barry Wolf
Journal:  Genet Med       Date:  2012-01-05       Impact factor: 8.822

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.